Company / Return on Assets (ROA)
Nuo Therapeutics, Inc. Return on Assets (ROA) History
FY2011-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-1051.8%
FY2017
5-year range
-1051.8% / -33.6%
FY2013-FY2017
Trend
-2495.9%
vs FY2016
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Return on Assets (ROA) changed -2496% YoY in FY2017, a notable deviation from the 6-year average annual change of -754%.
Based on SEC 10-K filings.
-1051.8% in FY2017 with a 5-year CAGR of -1007.2%.
Declined from -746.5% to -1051.8% over the past 2 years.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -1018.3pp
- 5-Year Change
- -1007.2pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2017, return on assets (roa) decreased 2495.9% year-over-year.
- Peak return on assets (roa) was recorded in FY2014.
Company context
Key Data Points
- Altman Z-Score -45.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2017 | -1051.8% | -2495.9% |
| FY2016 | -40.5% | +94.6% |
| FY2015 | -746.5% | -2122.5% |
| FY2014 | -33.6% | +23.3% |
| FY2013 | -43.8% | +2.0% |
| FY2012 | -44.7% | -28.2% |
| FY2011 | -34.8% | - |
As of FY2017 · SEC 10-K · Updated Jun 29, 2026